associ
robust
depress
antibodi
respons
clinic
sever
sar
remain
unknown
object
studi
seroconvers
magnitud
igg
respons
sar
cohort
differ
diseas
sever
studi
design
method
retrospect
analysi
acut
convalescentphas
sera
collect
cohort
laboratoryconfirm
sar
case
antisarscov
igg
antibodi
detect
use
indirect
immunofluoresc
techniqu
quantifi
twofold
serial
dilut
characterist
patient
seroconvert
earli
median
interv
compar
document
remain
seroneg
time
interv
median
igg
level
convalescentphas
sera
collect
within
day
compar
among
patient
differ
diseas
sever
correl
igg
level
import
laboratori
paramet
assess
result
total
laboratoryconfirm
sar
case
analyz
antisarscov
igg
detect
sera
time
sampl
igg
first
detect
day
ill
seroconvers
occur
median
day
rang
day
igg
peak
level
reach
fourth
week
earli
seroconvers
day
occur
frequent
among
patient
requir
icuadmiss
p
higher
igg
level
detect
patient
requir
supplement
oxygen
mannwhitney
p
icuadmiss
p
neg
predischarg
fecal
rtpcr
result
p
lymphopenia
present
p
peak
igg
titr
also
correl
posit
peak
ldh
level
spearman
r
p
among
survivor
conclus
sever
sar
associ
robust
igg
respons
sever
acut
respiratori
syndrom
sar
new
infecti
diseas
caus
novel
coronaviru
associ
signific
morbid
mortal
pathogenesi
appear
involv
high
viral
load
overexuber
immun
respons
peiri
et
al
b
howev
remain
unclear
whether
correspond
author
tel
fax
email
address
dschui
cuhkeduhk
ds
hui
robust
depress
antibodi
respons
associ
clinic
deterior
sever
diseas
cours
inform
may
improv
understand
sar
immunopathogenesi
facilit
design
appropri
therapeut
strategi
use
indirect
immunofluoresc
assay
ifa
chan
et
al
hsueh
et
al
evalu
antisarscov
igg
respons
within
first
month
ill
among
complet
cohort
sar
patient
rate
earli
seroconvers
magnitud
igg
respons
patient
differ
diseas
sever
compar
case
fulfil
cdc
case
definit
sar
admit
medic
ward
intens
care
unit
icu
princ
wale
hospit
hong
kong
sar
outbreak
year
includ
studi
lee
et
al
total
laboratoryconfirm
serolog
rtpcr
postmortem
sar
case
retrospect
evalu
antisarscov
igg
respons
clinic
diseas
sever
serum
sampl
first
collect
presentationadmiss
convalescentphas
sera
collect
either
beyond
week
ill
day
apart
acutephas
sera
serum
sampl
date
day
fever
onset
antisarscov
igg
detect
ifa
use
sarscovinfect
vero
cell
igg
titr
quantifi
twofold
serial
dilut
start
chan
et
al
routin
respiratori
specimen
collect
present
repeat
fecal
specimen
collect
upon
discharg
day
ill
test
sarscov
rtpcr
nonquantit
accord
recommend
chan
et
al
serolog
rtpcr
assay
sarscov
perform
contain
facil
accord
cdc
recommend
cdc
clinic
characterist
diseas
progress
investig
method
detail
treatment
cohort
patient
describ
elsewher
chan
et
al
gomersal
et
al
lee
et
al
lee
et
al
b
sung
et
al
sar
patient
requir
supplement
oxygen
therapi
cours
ill
admit
icu
result
sever
respiratori
failur
regard
sever
diseas
supplement
oxygen
prescrib
maintain
patient
oxygen
satur
necessari
sever
respiratori
failur
defin
failur
maintain
arteri
oxygen
satur
despit
receiv
supplement
oxygen
andor
respiratori
rate
greater
breath
per
minut
gomersal
et
al
highdos
corticosteroid
rescu
therapi
given
patient
clinic
radiolog
progress
note
accord
standard
protocol
sung
et
al
age
year
also
use
cutoff
comparison
group
sinc
epidemiolog
data
implic
advanc
age
poor
prognost
factor
thu
sever
diseas
cutoff
valu
lymphocyt
count
comparison
group
determin
base
earlier
studi
wong
et
al
retrospect
analysi
conduct
firstli
clinic
laboratori
variabl
patient
seroconvert
earli
median
interv
compar
case
document
remain
seroneg
time
interv
use
test
variabl
p
univari
analysi
enter
model
logist
regress
analysi
exclud
patient
first
serum
sampl
collect
day
sinc
igg
first
detect
day
cohort
first
sera
collect
beyond
day
median
interv
seroconvert
fever
onset
median
time
serum
collect
compar
patient
group
significantli
differ
secondli
median
antisarscov
igg
level
convalescentphas
sera
collect
within
day
compar
among
patient
differ
diseas
sever
laboratori
profil
use
mannwhitney
utest
variabl
p
univari
analysi
enter
nonparametr
regress
model
analysi
latest
serum
sampl
collect
patient
includ
analysi
median
time
collect
sampl
significantli
differ
compar
patient
group
thirdli
spearman
rank
correl
coeffici
use
assess
correl
igg
titr
ldh
level
lymphocyt
count
within
day
spss
window
releas
spss
inc
chicago
il
usa
use
analys
level
signific
set
comparison
total
laboratoryconfirm
sar
case
analyz
antisarscov
igg
detect
sera
time
sampl
case
convalescentphas
sera
collect
remain
case
one
serum
sampl
collect
within
first
day
ill
diagnos
confirm
rtpcr
sarscov
three
confirm
postmortem
total
patient
posit
rtpcr
result
respiratori
specimen
fecal
specimen
median
age
cohort
year
year
maletofemal
ratio
total
patient
admit
icu
median
age
year
patient
die
without
icu
care
median
age
year
patient
recov
without
icu
care
proport
patient
age
year
icuadmit
patient
without
icuadmiss
respect
crude
death
rate
patient
age
year
respect
signific
comorbid
ill
see
tabl
foot
note
present
case
age
year
respect
total
patient
requir
supplement
oxygen
stage
ill
highdos
corticosteroid
rescu
therapi
given
case
mean
ci
day
day
fever
onset
antisarscov
igg
respons
profil
cohort
report
previous
chan
et
al
igg
first
detect
day
seroconvers
occur
median
day
rang
day
igg
peak
level
reach
earli
fourth
week
ill
lowest
highest
igg
titr
respect
far
patient
late
serum
sampl
collect
month
postinfect
show
posit
igg
result
median
titr
rang
longest
interv
observ
day
month
characterist
patient
seroconvert
earli
day
compar
patient
remain
seroneg
period
result
shown
tabl
earli
seroconvers
observ
frequent
among
patient
requir
icuadmiss
p
although
reach
statist
signific
trend
toward
lower
proport
older
patient
year
age
observ
seroconvert
earli
p
result
logist
regress
analysi
indic
icuadmiss
factor
associ
earli
seroconvers
p
signific
differ
mortal
observ
earli
seroconvert
remain
seroneg
day
median
antisarscov
igg
level
convalescentphas
sera
collect
within
day
compar
among
patient
differ
diseas
sever
laboratori
profil
result
shown
tabl
igg
profil
patient
hadhad
receiv
supplement
oxygen
therapi
patient
hadhad
admit
icu
illustr
fig
b
higher
igg
level
detect
patient
requir
supplement
oxygen
p
icuadmiss
p
neg
predischarg
fecal
rtpcr
result
p
although
reach
statist
signific
trend
toward
lower
igg
level
detect
case
given
highdos
corticosteroid
therapi
nonprogressivemild
diseas
subgroup
patient
receiv
highdos
corticosteroid
treatment
analyz
case
higher
igg
level
detect
patient
sever
diseas
tabl
multivari
analysi
higher
igg
level
shown
associ
icuadmiss
p
supplement
oxygen
therapi
p
age
corticosteroid
treatment
p
corticosteroidtr
subgroup
absolut
lymphopenia
l
present
also
note
associ
higher
igg
titr
p
death
case
convalesc
sera
collect
allow
separ
analysi
examin
correl
antisarscov
igg
titr
ldh
level
lymphocyt
count
within
first
day
ill
posit
correl
peak
ldh
level
peak
igg
titr
spearman
r
p
neg
correl
initi
lymphocyt
count
peak
igg
titr
spearman
r
p
note
among
survivor
without
icuadmiss
correl
found
igg
titr
nadir
lymphocyt
count
icu
intens
care
unit
therpay
oxygen
supplement
requir
maintain
oxygen
satur
cs
intraven
highdos
corticosteroid
methylprednisolon
respiratori
fecal
specimen
fecal
fecal
specimen
collect
upon
discharg
day
includ
respiratori
specimen
rtpcr
neg
case
statist
signific
studi
shown
earli
seroconvers
day
occur
frequent
among
patient
requir
icuadmiss
addit
higher
igg
level
detect
patient
sever
diseas
evidenc
need
either
supplement
oxygen
icuadmiss
analysi
corticosteroidtr
subgroup
show
similar
result
peak
igg
titr
also
correl
posit
peak
ldh
level
indic
diseas
sever
among
survivor
antisarscov
igg
respons
profil
describ
consist
serolog
profil
report
elsewher
et
al
hsueh
et
al
li
et
al
igg
detect
earli
day
ifa
seroconvers
occur
end
second
week
igg
surg
peak
level
earli
fourth
week
report
second
late
rise
antibodi
titr
occur
week
possibl
relat
withdraw
corticosteroid
treatment
woo
et
al
thu
result
may
repres
initi
rate
chang
igg
level
within
first
month
also
need
interpret
context
corticosteroid
treatment
find
sever
sar
associ
robust
serolog
respons
support
earlier
observ
develop
humor
respons
coincid
tempor
diseas
progress
clinic
deterior
viral
load
start
decreas
hsueh
et
al
nie
et
al
peiri
et
al
also
patient
mild
diseas
rel
low
antibodi
titr
detect
lesssustain
respons
lee
et
al
tso
et
al
wildersmith
et
al
similar
phenomena
observ
viral
diseas
eg
dengu
hemorrhag
fever
immunopathogenesi
consid
import
thein
et
al
find
sever
import
clinic
implic
firstli
unlik
diseas
progress
clinic
deterior
result
depress
humor
respons
sarscov
fact
high
titr
antisarscov
igg
detect
patient
sever
diseas
natur
occur
neutral
antibodi
activ
associ
igg
may
contribut
viral
clearanc
extent
nie
et
al
temperton
et
al
clearli
confer
protect
diseas
progress
sar
also
support
find
higher
convalescentphas
igg
titr
associ
neg
predischarg
fecal
rtpcr
result
secondli
seem
possibl
robust
humor
respons
sarscov
one
compon
overal
exagger
immun
respons
sever
sar
associ
cytokin
storm
eg
ifngamma
huang
et
al
jiang
et
al
wong
et
al
briefli
mark
elev
cytokin
inflammatori
cytokin
note
initi
week
sar
chemokin
includ
neutrophil
chemokin
monocyt
chemoattract
chemokin
level
also
significantli
elev
fact
patient
detect
undetect
acut
antibodi
respons
compar
much
higher
initi
serum
ifngamma
level
note
former
huang
et
al
observ
invers
relationship
initi
lymphocyt
count
igg
level
also
agreement
previou
report
show
similar
invers
relationship
lymphocyt
count
ifngamma
level
possibl
cytokineinduc
apoptosi
huang
et
al
whether
humor
respons
contribut
directli
organ
damag
unclear
exact
immunopathogenesi
sar
requir
studi
final
sinc
higher
level
igg
associ
sever
diseas
use
convalesc
plasmapass
immun
treatment
sar
call
question
uncertain
whether
administr
exogen
antibodi
lead
aggrav
diseas
hsueh
et
al
suggest
therapi
contempl
given
earli
cours
ill
prophylaxi
greenough
et
al
jan
ter
meulen
et
al
nie
et
al
anecdot
report
shown
earli
use
convalesc
plasma
therapi
within
first
week
associ
lower
rate
intub
death
wherea
late
administr
associ
wors
clinic
outcom
cheng
et
al
soo
et
al
studi
limit
retrospect
natur
issu
delay
seroconvers
chang
antisarscov
igm
iga
neutral
antibodi
relat
diseas
sever
address
igg
respons
patient
without
corticosteroid
treatment
remain
poorli
character
nevertheless
find
suggest
sever
sar
associ
robust
igg
respons
studi
sar
immunopathogenesi
warrant
